SAMSCA is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Otsuka America Pharmaceutical, Inc.. The primary component is Tolvaptan.
Product ID | 59148-020_17d25d59-6f09-4e2e-9c87-382d4f780e4f |
NDC | 59148-020 |
Product Type | Human Prescription Drug |
Proprietary Name | SAMSCA |
Generic Name | Tolvaptan |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2009-05-19 |
Marketing Category | NDA / NDA |
Application Number | NDA022275 |
Labeler Name | Otsuka America Pharmaceutical, Inc. |
Substance Name | TOLVAPTAN |
Active Ingredient Strength | 15 mg/1 |
Pharm Classes | Vasopressin V2 Receptor Antagonist [EPC], Vasopressin V2 Receptor Antagonists [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2009-05-19 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA022275 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2009-05-19 |
Ingredient | Strength |
---|---|
TOLVAPTAN | 15 mg/1 |
SPL SET ID: | 5526617c-c7b9-4556-886d-729bbabbc566 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
59148-020 | SAMSCA | tolvaptan |
59148-021 | SAMSCA | tolvaptan |
59148-079 | Jynarque | tolvaptan |
59148-080 | Jynarque | tolvaptan |
59148-082 | JYNARQUE | tolvaptan |
59148-083 | JYNARQUE | tolvaptan |
59148-087 | Jynarque | tolvaptan |
59148-088 | Jynarque | tolvaptan |
31722-868 | Tolvaptan | Tolvaptan |
31722-869 | Tolvaptan | Tolvaptan |
49884-768 | Tolvaptan | Tolvaptan |
49884-770 | Tolvaptan | Tolvaptan |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
SAMSCA 76692397 3687896 Live/Registered |
Otsuka Pharmaceutical Co., Ltd. 2008-08-26 |